Response to ‘Phase IV head-to-head randomized controlled trial comparing ingenol mebutate 0·015% gel with diclofenac sodium 3% gel for the treatment of actinic keratosis on the face or scalp’: reply from the authors

2018 ◽  
Vol 178 (3) ◽  
pp. 813-814 ◽  
Author(s):  
E. Stockfleth ◽  
C.A. Harwood ◽  
C. Serra-Guillén ◽  
T. Larsson ◽  
M.L. Østerdal ◽  
...  
Keyword(s):  
Randomized Controlled Trial ◽  
Actinic Keratosis ◽  
Controlled Trial ◽  
Diclofenac Sodium ◽  
Ingenol Mebutate ◽  
Randomized Controlled ◽  
The Face ◽  
Phase Iv

scholarly journals Efficacy and Safety of Ingenol Mebutate Gel in Field Treatment of Actinic Keratosis on Full Face, Balding Scalp, or Approximately 250 cm2 on the Chest: A Phase III, Randomized, Controlled Trial

2018 ◽  
Vol 2 ◽  
pp. S46 ◽  
Author(s):  
C William Hanke ◽  
Lorne Albrecht ◽  
Laerke K Kyhl ◽  
Thomas Larrson ◽  
Marie L Oesterdal ◽  
...  
Keyword(s):  
Randomized Controlled Trial ◽  
Actinic Keratosis ◽  
Controlled Trial ◽  
Phase Iii ◽  
Efficacy And Safety ◽  
Ingenol Mebutate ◽  
Randomized Controlled ◽  
Full Face

Abstract not available. Disclosures: Study supported by LEO Pharma. Copyright SKIN 2018

Randomized Controlled Trial of Diclofenac Sodium Gel in Knee Osteoarthritis

2009 ◽  
Vol 39 (3) ◽  
pp. 203-212 ◽  
Author(s):  
H. Richard Barthel ◽  
Douglas Haselwood ◽  
Selden Longley ◽  
Morris S. Gold ◽  
Roy D. Altman
Keyword(s):  
Randomized Controlled Trial ◽  
Knee Osteoarthritis ◽  
Controlled Trial ◽  
Diclofenac Sodium ◽  
Randomized Controlled
Sign in / Sign up

Export Citation Format

Share Document